GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (XSWX:CLS1) » Definitions » Cyclically Adjusted Price-to-FCF

McKesson Europe AG (XSWX:CLS1) Cyclically Adjusted Price-to-FCF : (As of Jun. 20, 2024)


View and export this data going back to 2014. Start your Free Trial

What is McKesson Europe AG Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


McKesson Europe AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for McKesson Europe AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Cyclically Adjusted Price-to-FCF Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.92 14.58 16.24 20.37 20.87

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.92 14.58 16.24 20.37 20.87

Competitive Comparison of McKesson Europe AG's Cyclically Adjusted Price-to-FCF

For the Medical Distribution subindustry, McKesson Europe AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Cyclically Adjusted Price-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Cyclically Adjusted Price-to-FCF falls into.



McKesson Europe AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

McKesson Europe AG's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar22 is calculated as:

For example, McKesson Europe AG's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar22 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar22 (Change)*Current CPI (Mar22)
=0.005/113.9681*113.9681
=0.005

Current CPI (Mar22) = 113.9681.

McKesson Europe AG Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 2.146 97.957 2.497
201312 1.974 99.356 2.264
201412 0.561 99.543 0.642
201603 0.747 100.017 0.851
201703 1.405 101.417 1.579
201803 0.794 102.917 0.879
201903 1.156 104.217 1.264
202003 0.961 105.718 1.036
202103 1.428 107.518 1.514
202203 0.005 113.968 0.005

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


McKesson Europe AG  (XSWX:CLS1) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


McKesson Europe AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (XSWX:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (XSWX:CLS1) Headlines

No Headlines